Publication | Open Access

Posttransplant peripheral blood donor–specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients

Transplant RejectionDonor-specific AlloantibodiesTransplantationAutoimmune DiseaseKidney TransplantMedicineKidney TransplantationImmunologyHematologyPathologyKidney Transplant RecipientsAutoimmunityGraft SurvivalDifferentiates RiskImmunotherapyTransplant ImmunologyCell TransplantationGraft Rejection